Silexion Therapeutics Ltd. Stock Analysis & AI Score
Silexion Therapeutics Ltd. (SLXN) has an ST Score of 22.4 (D+), driven by its Growth (C+) and held back by its Financial Strength (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Silexion Therapeutics Ltd. (SLXN) has an ST Score of 22.4 (D+), driven by its Growth (C+) and held back by its Financial Strength (F). Analysts rate it Buy.
- Strongest
- GrowthC+
- Weakest
- Financial StrengthF
All factor grades
- GrowthC+
- ProfitabilityC-
- ValuationD
- MomentumD
- Financial StrengthF
- Piotroski2/9
Contact
SLXN stock: frequently asked questions
What is SLXN's ST Score?
Silexion Therapeutics Ltd. (SLXN) has an ST Score of 22.4 (D+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SLXN a buy, hold, or sell?
Analysts rate SLXN a Buy. Our ST Score grades it D+ (22.4/100). The ST Score is a data-driven signal, not a recommendation.
What are SLXN's factor grades?
Valuation D, Profitability C-, Financial Strength F, Momentum D, Growth C+.
What is SLXN's valuation grade?
Silexion Therapeutics Ltd. (SLXN) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SLXN's growth grade?
Silexion Therapeutics Ltd. (SLXN) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SLXN's profitability grade?
Silexion Therapeutics Ltd. (SLXN) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SLXN's financial strength grade?
Silexion Therapeutics Ltd. (SLXN) earns a financial strength grade of F, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is SLXN's Piotroski score?
Silexion Therapeutics Ltd. (SLXN) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.